Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30
Published February 15, 2017 · Recall initiated: October 13, 2016
Summary
FDA records drug Class III recall D-0468-2017, published February 15, 2017 and initiated October 13, 2016. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 5,904 bottles; Lot: C500202. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.
What to do
Voluntary: Firm initiated · Letter
Get an email if OLANZAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OLANZAPINE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- US Nationwide
- Lot
- C500202
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOlanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton,September 30, 2026
- FDAOlanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc.December 25, 2024
- FDAOlanzapine Tablets, USP 10 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA , Inc.March 9, 2022
- FDAPotassium Chloride Oral Solution, USP, 10%, 20 mEq per 15 mL, packaged in 15 mL unit dose cups (NDCFebruary 15, 2017
- FDAIntact Disposable Wands (part of the Intact System) 777-120BT: 5 Pack 20mm Disposable Product Usage: TheFebruary 8, 2017
- FDAIntact Disposable Wands (part of the Intact System) 900-120: 5 Pack 20mm Disposable Product Usage: The IntactFebruary 8, 2017
Questions about this recall
Was Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30 recalled?
Yes. FDA published recall D-0468-2017 on February 15, 2017. Reported hazard: Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OLANZAPINE.